Research Summary
An influenza vaccine, commonly known as the flu shot, is a preventive medical treatment designed to protect individuals from infection by the influenza virus. Influenza vaccines contain inactivated or weakened strains of the influenza virus or its components, stimulating the immune system to develop antibodies. These antibodies can recognize and neutralize the virus when the body encounters it, reducing the severity of illness and the risk of complications if exposed to the flu. Influenza vaccines are administered annually, typically before the flu season, and are especially recommended for individuals at higher risk of complications, such as the elderly, young children, pregnant women, and people with certain medical conditions. Mass vaccination programs have contributed to the reduction of flu-related illnesses and hospitalizations, making the influenza vaccine a crucial tool in public health efforts to prevent the spread of the flu.
According to WENKH research statistics, the global Influenza Vaccine market size will reach 10,790 Million USD in 2025 and is projected to reach 16,011 Million USD by 2032, with a CAGR of 5.80% (2025-2032). Among them, the Asia-Pacific Influenza Vaccine market is undergoing rapid changes, reaching Million USD in 2025, accounting for approximately % of the global market share. It is projected to reach Million USD by 2032.
The global Influenza Vaccine market is characterized by a highly consolidated structure in developed regions and increasingly fragmented competition in emerging markets. In North America and Europe, major pharmaceutical companies such as Sanofi, CSL, GlaxoSmithKline, Viatris, and AstraZeneca dominate market share with well-established distribution networks and advanced manufacturing capabilities. Sanofi and CSL remain at the forefront, leveraging strong pipelines and extensive regulatory experience. Sanofi continues to benefit from its quadrivalent influenza vaccine portfolio, while CSL’s Seqirus unit maintains a competitive edge through its cell-based and adjuvanted formulations, which are gaining traction for their enhanced efficacy. GlaxoSmithKline maintains a notable presence through strategic procurement contracts and seasonal product launches, while Viatris and AstraZeneca contribute with a focus on intranasal delivery platforms and cost-effective vaccine solutions.
The competitive landscape in Asia is more diversified and dynamic, driven by the presence of regional players and growing domestic demand. Chinese manufacturers such as Hualan Biological Engineering, Changchun Institute of Biological Products, Sinovac Biotech, BCHT Biotechnology, and Jiangsu GDK Biotechnology are actively expanding production capacity and accelerating research in response to public health initiatives. Sinovac and Hualan Bio have established themselves as leading suppliers to national immunization programs, with product lines tailored for both public procurement and private distribution. BCHT and Changchun Institute of Biological Products are also enhancing competitiveness by investing in next-generation vaccine technologies. In Japan, KM Biologics plays a significant role, supported by strong governmental backing and domestic trust in locally produced vaccines.
The global Influenza Vaccine market is highly competitive, with key market players including Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics, etc. This report categorizes the competitive landscape of the global Influenza Vaccine market into three tiers based on annual revenue, with the top three market players holding approximately % of the total market share.
This report provides an in-depth analysis of the global Influenza Vaccine market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, sales revenue, and gross profit margin of major players in the global Influenza Vaccine industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different product segments of Influenza Vaccine and their downstream application fields.
In terms of data, this report includes a comprehensive time-series dataset. The historical data spans from 2020 to 2024, providing a solid foundation for analyzing past market trends. The year 2025 is used as a base year to accurately assess the current market landscape. Forecast data covers the period from 2026 to 2032, utilizing scientific analysis methods and models to offer forward-looking predictions and insights into the market's future development. This provides valuable reference information for industry participants and stakeholders.
The report covers countries including United States, China, Germany, Japan, France, South Korea, United Kingdom, India, Italy, Brazil, Mexico, Indonesia, Vietnam and South Africa. It particularly focuses on the sales revenue of Influenza Vaccine in these countries, as well as the product segmentation and downstream application market size of each country. The report provides an in-depth analysis of the regional distribution and future development trends of the Influenza Vaccine market. By considering local policies, this report evaluates the market prospects of Influenza Vaccine in each country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.
This report places a strong emphasis on data quality and reliability, utilizing diverse and extensive data sources to ensure the accuracy and validity of the information presented. Primary data collection involves multiple channels, including in-depth interviews with senior executives, industry experts, supply chain stakeholders, and end consumers. These interviews provide key insights into corporate strategic planning, industry policy interpretation, supply chain dynamics, and end-user experiences. Secondary data sources cover a wide range of authoritative statistics from government agencies, customs databases, industry associations, third-party paid databases, brokerage research reports, academic research findings, corporate annual reports, financial statements, real-time news updates, and relevant information from international organizations. These data sources serve as a solid foundation for verification and analysis.
Companies Covered
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Product Segment
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Product Application
6 Months to 3 Years
＞ 3 Years
Chapter Scope
Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects
Chapter 2: Global Influenza Vaccine Industry Chain Analysis
Chapter 3: Global Influenza Vaccine Industry Environment Analysis and Porter's Five Forces Analysis
Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Influenza Vaccine Market (Market Share, Product Revenue Comparison, Tier Division, Corporate Expansion and M&A Trends)
Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Specifications and Features, Product Revenue and Product Gross Profit Margin)
Chapter 6: Global Influenza Vaccine Market Analysis by Countries, Product Segment and Downstream Application
Chapter 7: United States Influenza Vaccine Market Size, Product Segment, Downstream Application Analysis
Chapter 8: China Influenza Vaccine Market Size, Product Segment, Downstream Application Analysis
Chapter 9: Germany Influenza Vaccine Market Size, Product Segment, Downstream Application Analysis
Chapter 10: Japan Influenza Vaccine Market Size, Product Segment, Downstream Application Analysis
Chapter 11: France Influenza Vaccine Market Size, Product Segment, Downstream Application Analysis
Chapter 12: South Korea Influenza Vaccine Market Size, Product Segment, Downstream Application Analysis
Chapter 13: United Kingdom Influenza Vaccine Market Size, Product Segment, Downstream Application Analysis
Chapter 14: India Influenza Vaccine Market Size, Product Segment, Downstream Application Analysis
Chapter 15: Italy Influenza Vaccine Market Size, Product Segment, Downstream Application Analysis
Chapter 16: Brazil Influenza Vaccine Market Size, Product Segment, Downstream Application Analysis
Chapter 17: Mexico Influenza Vaccine Market Size, Product Segment, Downstream Application Analysis
Chapter 18: Indonesia Influenza Vaccine Market Size, Product Segment, Downstream Application Analysis
Chapter 19: Vietnam Influenza Vaccine Market Size, Product Segment, Downstream Application Analysis
Chapter 20: South Africa Influenza Vaccine Market Size, Product Segment, Downstream Application Analysis
Chapter 21: Research Conclusion
Chapter 22: Methodology and Data Source
Purpose and Value of the Report
Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.
Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.
Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.
Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.
Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.
Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.
Table of Content
1 Influenza Vaccine Market Overview
1.1 Product Definition Introduction
1.2 Global Influenza Vaccine Market Size and Growth Forecast Analysis (2020-2032)
1.3 Influenza Vaccine Market Status and Development Prospects
1.3.1 Influenza Vaccine Market Status
1.3.2 Influenza Vaccine Industry Development Prospects
1.4 Influenza Vaccine Market Overview by Product Segment
1.4.1 Global Influenza Vaccine Market Size and Growth Forecast Analysis by Product Segment: 2020 VS 2025 VS 2032
1.4.2 Trivalent Influenza Vaccine
1.4.3 Quadrivalent Influenza Vaccine
1.5 Influenza Vaccine Market Overview by Product Application
1.5.1 Global Influenza Vaccine Market Size and Growth Forecast Analysis by Product Application: 2020 VS 2025 VS 2032
1.5.2 6 Months to 3 Years
1.5.3 ＞ 3 Years
2 Influenza Vaccine Industry Supply Chain Analysis
2.1 Influenza Vaccine Supply Chain
2.2 Influenza Vaccine Midstream Suppliers
2.3 Influenza Vaccine Downstream Customers
2.4 Influenza Vaccine Sales Channel Analysis
3 Influenza Vaccine Market Environment Analysis
3.1 Influenza Vaccine Industry Policy Analysis
3.2 Influenza Vaccine Emerging Technology Trends in the Industry
3.3 Influenza Vaccine Restraining Factors Analysis
3.4 Influenza Vaccine Market Porter's Five Forces Analysis
3.4.1 Competitive Rivalry
3.4.2 Threat of New Entrants
3.4.3 Bargaining Power of Suppliers
3.4.4 Bargaining Power of Buyers
3.4.5 Threat of Substitute Products or Services
4 Global Influenza Vaccine Market Players Competition Landscape
4.1 Global Influenza Vaccine Market Revenue by Key Players (2021-2025)
4.2 Global Influenza Vaccine Market Position by Key Players
4.3 Global Key Players Headquarter and Key Area Served
4.4 Global Influenza Vaccine Market Expansion and M&A Dynamic
5 In-depth Analysis of Key Players
5.1 Sanofi
5.1.1 Sanofi Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.1.2 Sanofi Influenza Vaccine Product Features
5.1.3 Sanofi Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2025)
5.2 CSL
5.2.1 CSL Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.2.2 CSL Influenza Vaccine Product Features
5.2.3 CSL Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2025)
5.3 GSK
5.3.1 GSK Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.3.2 GSK Influenza Vaccine Product Features
5.3.3 GSK Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2025)
5.4 Viatris
5.4.1 Viatris Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.4.2 Viatris Influenza Vaccine Product Features
5.4.3 Viatris Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2025)
5.5 AstraZeneca
5.5.1 AstraZeneca Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.5.2 AstraZeneca Influenza Vaccine Product Features
5.5.3 AstraZeneca Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2025)
5.6 Hualan Bio
5.6.1 Hualan Bio Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.6.2 Hualan Bio Influenza Vaccine Product Features
5.6.3 Hualan Bio Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2025)
5.7 Changchun Institute of Biological
5.7.1 Changchun Institute of Biological Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.7.2 Changchun Institute of Biological Influenza Vaccine Product Features
5.7.3 Changchun Institute of Biological Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2025)
5.8 Sinovac
5.8.1 Sinovac Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.8.2 Sinovac Influenza Vaccine Product Features
5.8.3 Sinovac Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2025)
5.9 BCHT
5.9.1 BCHT Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.9.2 BCHT Influenza Vaccine Product Features
5.9.3 BCHT Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2025)
5.10 Jiangsu GDK
5.10.1 Jiangsu GDK Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.10.2 Jiangsu GDK Influenza Vaccine Product Features
5.10.3 Jiangsu GDK Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2025)
5.11 KM Biologics
5.11.1 KM Biologics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.11.2 KM Biologics Influenza Vaccine Product Features
5.11.3 KM Biologics Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2025)
6 Global Influenza Vaccine Market Analysis by Countries, by Product Segment and Application
6.1 Global Influenza Vaccine Market Size and Growth Forecast by Countries: 2020 VS 2025 VS 2032
6.1.1 Global Influenza Vaccine Market Revenue by Countries (2020-2025)
6.1.2 Global Influenza Vaccine Market Revenue Forecast by Countries (2026-2032)
6.2 Global Influenza Vaccine Market Size by Product Segment (2020-2032)
6.3 Global Influenza Vaccine Market Size by Product Application (2020-2032)
7 United States Influenza Vaccine Market Analysis
7.1 United States Influenza Vaccine Market Prospects
7.2 United States Influenza Vaccine Market Size by Product Segment (2020-2032)
7.3 United States Influenza Vaccine Market Size by Product Application (2020-2032)
8 China Influenza Vaccine Market Analysis
8.1 China Influenza Vaccine Market Prospects
8.2 China Influenza Vaccine Market Size by Product Segment (2020-2032)
8.3 China Influenza Vaccine Market Size by Product Application (2020-2032)
9 Germany Influenza Vaccine Market Analysis
9.1 Germany Influenza Vaccine Market Prospects
9.2 Germany Influenza Vaccine Market Size by Product Segment (2020-2032)
9.3 Germany Influenza Vaccine Market Size by Product Application (2020-2032)
10 Japan Influenza Vaccine Market Analysis
10.1 Japan Influenza Vaccine Market Prospects
10.2 Japan Influenza Vaccine Market Size by Product Segment (2020-2032)
10.3 Japan Influenza Vaccine Market Size by Product Application (2020-2032)
11 France Influenza Vaccine Market Analysis
11.1 France Influenza Vaccine Market Prospects
11.2 France Influenza Vaccine Market Size by Product Segment (2020-2032)
11.3 France Influenza Vaccine Market Size by Product Application (2020-2032)
12 South Korea Influenza Vaccine Market Analysis
12.1 South Korea Influenza Vaccine Market Prospects
12.2 South Korea Influenza Vaccine Market Size by Product Segment (2020-2032)
12.3 South Korea Influenza Vaccine Market Size by Product Application (2020-2032)
13 United Kingdom Influenza Vaccine Market Analysis
13.1 United Kingdom Influenza Vaccine Market Prospects
13.2 United Kingdom Influenza Vaccine Market Size by Product Segment (2020-2032)
13.3 United Kingdom Influenza Vaccine Market Size by Product Application (2020-2032)
14 India Influenza Vaccine Market Analysis
14.1 India Influenza Vaccine Market Prospects
14.2 India Influenza Vaccine Market Size by Product Segment (2020-2032)
14.3 India Influenza Vaccine Market Size by Product Application (2020-2032)
15 Italy Influenza Vaccine Market Analysis
15.1 Italy Influenza Vaccine Market Prospects
15.2 Italy Influenza Vaccine Market Size by Product Segment (2020-2032)
15.3 Italy Influenza Vaccine Market Size by Product Application (2020-2032)
16 Brazil Influenza Vaccine Market Analysis
16.1 Brazil Influenza Vaccine Market Prospects
16.2 Brazil Influenza Vaccine Market Size by Product Segment (2020-2032)
16.3 Brazil Influenza Vaccine Market Size by Product Application (2020-2032)
17 Mexico Influenza Vaccine Market Analysis
17.1 Mexico Influenza Vaccine Market Prospects
17.2 Mexico Influenza Vaccine Market Size by Product Segment (2020-2032)
17.3 Mexico Influenza Vaccine Market Size by Product Application (2020-2032)
18 Indonesia Influenza Vaccine Market Analysis
18.1 Indonesia Influenza Vaccine Market Prospects
18.2 Indonesia Influenza Vaccine Market Size by Product Segment (2020-2032)
18.3 Indonesia Influenza Vaccine Market Size by Product Application (2020-2032)
19 Vietnam Influenza Vaccine Market Analysis
19.1 Vietnam Influenza Vaccine Market Prospects
19.2 Vietnam Influenza Vaccine Market Size by Product Segment (2020-2032)
19.3 Vietnam Influenza Vaccine Market Size by Product Application (2020-2032)
20 South Africa Influenza Vaccine Market Analysis
20.1 South Africa Influenza Vaccine Market Prospects
20.2 South Africa Influenza Vaccine Market Size by Product Segment (2020-2032)
20.3 South Africa Influenza Vaccine Market Size by Product Application (2020-2032)
21 Research Conclusion
22 Appendix
22.1 Methodology/Research Approach
22.2 Research Landscape
22.3 Research Benchmark and Hypothesis
22.4 Data Source
22.4.1 Primary Sources
22.4.2 Secondary Sources
22.5 Data Cross Validation
22.6 Disclaimer
Table 1：Global Influenza Vaccine Market Size and Growth Forecast Analysis by Product Segment (2020 VS 2025 VS 2032) & (Million USD)
Table 2：Global Influenza Vaccine Market Size and Growth Forecast Analysis by Product Application (2020 VS 2025 VS 2032) & (Million USD)
Table 3：Influenza Vaccine Downstream Customers List
Table 4：Influenza Vaccine Distributors/Dealers List
Table 5：Global Influenza Vaccine Market Revenue by Key Players (2021-2025) & (Million USD)
Table 6：Global Influenza Vaccine Market Position by Key Players
Table 7：Global Key Players Headquarter and Key Area Served
Table 8：Global Influenza Vaccine Market Expansion and M&A Dynamic
Table 9：Sanofi Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 10：Sanofi Influenza Vaccine Product Features
Table 11：Sanofi Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2025)
Table 12：CSL Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 13：CSL Influenza Vaccine Product Features
Table 14：CSL Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2025)
Table 15：GSK Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 16：GSK Influenza Vaccine Product Features
Table 17：GSK Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2025)
Table 18：Viatris Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 19：Viatris Influenza Vaccine Product Features
Table 20：Viatris Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2025)
Table 21：AstraZeneca Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 22：AstraZeneca Influenza Vaccine Product Features
Table 23：AstraZeneca Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2025)
Table 24：Hualan Bio Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 25：Hualan Bio Influenza Vaccine Product Features
Table 26：Hualan Bio Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2025)
Table 27：Changchun Institute of Biological Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 28：Changchun Institute of Biological Influenza Vaccine Product Features
Table 29：Changchun Institute of Biological Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2025)
Table 30：Sinovac Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 31：Sinovac Influenza Vaccine Product Features
Table 32：Sinovac Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2025)
Table 33：BCHT Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 34：BCHT Influenza Vaccine Product Features
Table 35：BCHT Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2025)
Table 36：Jiangsu GDK Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 37：Jiangsu GDK Influenza Vaccine Product Features
Table 38：Jiangsu GDK Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2025)
Table 39：KM Biologics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 40：KM Biologics Influenza Vaccine Product Features
Table 41：KM Biologics Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2025)
Table 42：Global Influenza Vaccine Market Size and Growth Forecast by Countries (2020 VS 2025 VS 2032) & (Million USD)
Table 43：Global Influenza Vaccine Market Revenue by Countries (2020-2025) & (Million USD)
Table 44：Global Influenza Vaccine Market Share by Countries (2020-2025)
Table 45：Global Influenza Vaccine Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 46：Global Influenza Vaccine Market Share Forecast by Countries (2026-2032)
Table 47：Global Influenza Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 48：Global Influenza Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 49：Global Influenza Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)
Table 50：Global Influenza Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 51：United States Influenza Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 52：United States Influenza Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 53：United States Influenza Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)
Table 54：United States Influenza Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 55：China Influenza Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 56：China Influenza Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 57：China Influenza Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)
Table 58：China Influenza Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 59：Germany Influenza Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 60：Germany Influenza Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 61：Germany Influenza Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)
Table 62：Germany Influenza Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 63：Japan Influenza Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 64：Japan Influenza Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 65：Japan Influenza Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)
Table 66：Japan Influenza Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 67：France Influenza Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 68：France Influenza Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 69：France Influenza Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)
Table 70：France Influenza Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 71：South Korea Influenza Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 72：South Korea Influenza Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 73：South Korea Influenza Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)
Table 74：South Korea Influenza Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 75：United Kingdom Influenza Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 76：United Kingdom Influenza Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 77：United Kingdom Influenza Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)
Table 78：United Kingdom Influenza Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 79：India Influenza Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 80：India Influenza Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 81：India Influenza Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)
Table 82：India Influenza Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 83：Italy Influenza Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 84：Italy Influenza Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 85：Italy Influenza Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)
Table 86：Italy Influenza Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 87：Brazil Influenza Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 88：Brazil Influenza Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 89：Brazil Influenza Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)
Table 90：Brazil Influenza Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 91：Mexico Influenza Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 92：Mexico Influenza Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 93：Mexico Influenza Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)
Table 94：Mexico Influenza Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 95：Indonesia Influenza Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 96：Indonesia Influenza Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 97：Indonesia Influenza Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)
Table 98：Indonesia Influenza Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 99：Vietnam Influenza Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 100：Vietnam Influenza Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 101：Vietnam Influenza Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)
Table 102：Vietnam Influenza Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 103：South Africa Influenza Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 104：South Africa Influenza Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 105：South Africa Influenza Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)
Table 106：South Africa Influenza Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 107：Secondary Sources
Figure 1：Influenza Vaccine Product Scope
Figure 2：Global Influenza Vaccine Market Size and Growth Forecast Analysis (2020-2032) & (Million USD)
Figure 3：Global Influenza Vaccine Product Segment Market Share (2025 & 2032)
Figure 4：Global Influenza Vaccine Product Application Market Share (2025 & 2032)
Figure 5：Trivalent Influenza Vaccine Product Scope
Figure 6：Quadrivalent Influenza Vaccine Product Scope
Figure 7：6 Months to 3 Years Product Scope
Figure 8：＞ 3 Years Product Scope
Figure 9：Influenza Vaccine Industrial Chain Framework
Figure 10：Global Influenza Vaccine Market by Geographic Segmentation in 2025
Figure 11：Global Influenza Vaccine Market Share by Countries (2020 VS 2025)
Figure 12：United States Influenza Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 13：China Influenza Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 14：Germany Influenza Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 15：Japan Influenza Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 16：France Influenza Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 17：South Korea Influenza Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 18：United Kingdom Influenza Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 19：India Influenza Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 20：Italy Influenza Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 21：Brazil Influenza Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 22：Mexico Influenza Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 23：Indonesia Influenza Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 24：Vietnam Influenza Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 25：South Africa Influenza Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 26：Research Methodology
Figure 27：Primary Sources
Figure 28：Data Cross Validation
Global Influenza Vaccine Revenue and Market Share by Key Players
| Revenue (US$ Million) | 2020 | 2021 | 2022 | 2023 | 2024 |
| Sanofi | XX | XX | XX | XX | XX |
| CSL | XX | XX | XX | XX | XX |
| GSK | XX | XX | XX | XX | XX |
| Viatris | XX | XX | XX | XX | XX |
| AstraZeneca | XX | XX | XX | XX | XX |
| Hualan Bio | XX | XX | XX | XX | XX |
| Changchun Institute of Biological | XX | XX | XX | XX | XX |
| Sinovac | XX | XX | XX | XX | XX |
| BCHT | XX | XX | XX | XX | XX |
| Jiangsu GDK | XX | XX | XX | XX | XX |
| KM Biologics | XX | XX | XX | XX | XX |
| Other Companies | XX | XX | XX | XX | XX |
| Total | XX | XX | XX | XX | XX |
English
Related Reports 
